This post was originally published on this site
Original post: Newswise - Drug and Drug Abuse Immunocompromised dialysis patients could benefit from mRNA COVID-19 vaccine third doses
Patients receiving in-hospital dialysis treatment for kidney disease produce a larger neutralising antibody response when given the Pfizer-BioNTech COVID-19 vaccine, compared to the Oxford-AstraZeneca vaccine, according to laboratory findings published today (Thursday) as a Correspondence in The Lancet.